Skip to main content
Atul Limited. logo

Atul Limited. — Investor Relations & Filings

Ticker · ATUL ISIN · INE100A01010 LEI · 335800RE4LWLLDL2OQ62 BSE.NS Manufacturing
Open in API
Filings indexed 1,340 across all filing types
Latest filing 2024-08-10 Regulatory Filings
Country IN India
Listing BSE.NS ATUL

About Atul Limited.

https://www.atul.co.in/

Atul Limited is an integrated chemical company that manufactures a diverse range of products across several business segments, including Life Science Chemicals and Performance and Other Chemicals. The company's portfolio encompasses aromatics, bulk chemicals, colors, crop protection agents, polymers, and pharmaceutical intermediates. These products serve a broad spectrum of applications in sectors such as agriculture, construction, textiles, automotive, and healthcare. The organization focuses on complex chemical synthesis and large-scale production, leveraging research and development to optimize manufacturing processes. By maintaining a comprehensive supply chain and diverse manufacturing capabilities, the company provides essential raw materials and specialized formulations to a global customer base while adhering to standards of operational efficiency and environmental responsibility.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding information about a duplicate register of share certificates issued on duplication. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate matters. The content includes details about old and new share certificates issued due to duplication, with no financial statements or performance data. This is a regulatory announcement related to share certificates and compliance, not a financial report or earnings release. It does not fit into categories like Annual Report, Earnings Release, or Capital/Financing Update. It is a regulatory filing informing the exchanges about share certificate duplication as per regulatory requirements. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is short and it is an announcement rather than a report itself, confirming the classification.
2024-08-10 English
Letter attached
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Atul Bioscience Ltd, a subsidiary of Atul Ltd, has received the Establishment Inspection Report (EIR) from the US FDA for its manufacturing facility. It references Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, which pertains to disclosure of material events. The document is short (4110 characters) and primarily serves as an announcement of the receipt of the EIR, not the report itself. There are no financial statements or detailed financial data present. Therefore, this is an announcement of a regulatory event rather than a full report or detailed filing. It fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-09 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Atul Bioscience Ltd, a subsidiary of Atul Ltd, has received the Establishment Inspection Report (EIR) from the US FDA for its manufacturing facility. It references Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, which pertains to disclosure of material events. The document is relatively short (4110 characters) and primarily serves as an announcement of the receipt of the EIR, not the report itself. There are no financial statements or detailed financial data presented. Therefore, this is an announcement of a regulatory event rather than a full report or detailed filing. Given the nature of the content and the regulatory context, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-09 English
Letter attached
AGM Information Classification · 95% confidence The document is a letter addressed to stock exchanges informing them that the speech delivered by the Chairman and Managing Director at the 47th Annual General Meeting (AGM) has been uploaded on the company's website. The document does not contain the speech text itself, nor any financial data or detailed report content. It is essentially an announcement about the availability of AGM materials. The document length is short (1408 characters), and it explicitly states that the speech is available via a link, indicating it is a notification rather than the report itself. Therefore, this fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM.
2024-08-08 English
Updates
AGM Information Classification · 95% confidence The document is a letter addressed to stock exchanges informing them that the speech delivered by the Chairman and Managing Director at the 47th Annual General Meeting (AGM) has been uploaded on the company's website. The document does not contain the speech itself or any detailed financial data, but rather announces the availability of AGM materials. The document length is short (1408 characters), and it explicitly states that the speech is available via a link, indicating it is an announcement rather than the report or speech content itself. Therefore, this fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM.
2024-08-08 English
Letter attached
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges referencing Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It provides information about a duplicate register of share certificates issued on duplication, including detailed tabular data about share certificates and shareholders. The content is a regulatory compliance communication about share certificate duplication, not a financial report, earnings release, or management discussion. It is not announcing voting results, board changes, or capital changes. The document is a regulatory announcement related to share registry and compliance, fitting best under Regulatory Filings (RNS). The document length is about 5,327 characters, which is not a brief announcement of a report but a substantive regulatory communication. Therefore, the classification is RNS with high confidence.
2024-08-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.